FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging

Manuscript Number: 

16-0326R1

Author(s): 
Teresa J.H. Christianson, Yonas E. Geda, Clifford R. Jack Jr., David S. Knopman, Janina Krell-Roesch, Val J. Lowe, Mary M. Machulda, Michelle M. Mielke, Ronald C. Petersen, Anna Pink, Rosebud Roberts, Hanna Ruider, Gorazd B. Stokin

Disclosures

Teresa J.H. Christianson

  • Nothing to Disclose

Yonas E. Geda

  • Nothing to Disclose

Clifford R. Jack Jr.

  • Consulting Fees:
    Eli Lily Co
    Grants
    • Agency: 
      NIH
    • Agency: 
      Alexander Family Alzheimer's Disease Research Professorship of the Mayo Foundation.

David S. Knopman

  • Consulting Fees:
    DSMB for Lundbeck AD clinical trial; DSMB for DIAN study
    Grants
    • Agency: 
      Lilly - for site participation in A4 study
      Dates: 
      ongoing
    • Agency: 
      TAURX - for site participation in FTD clinical trial
      Dates: 
      ongoing
    • Agency: 
      Biogen - for site participation in AD clinical trial
      Dates: 
      ongoing

Janina Krell-Roesch

  • Nothing to Disclose

Val J. Lowe

  • Grants
    • Agency: 
      AVID Radiopharmaceuticals
      Dates: 
      August, 2007 to present
    • Agency: 
      GE Healthcare
      Dates: 
      March 2009 to present

Mary M. Machulda

  • Nothing to Disclose

Michelle M. Mielke

  • Consulting Fees:
    I have consulted for Lysosomal Therapuetics, Inc and am on the scientific review board of the Alzheimer's Drug Discovery Foundation.

Ronald C. Petersen

  • Consulting Fees:
    Pfizer, Inc., and Janssen Alzheimer Immunotherapy: Chair, Data Monitoring Committee Hoffman-La Roche, Inc.: Consultant Merck, Inc.: Consultant Genentech, Inc.: Consultant Biogen, Inc.: Consultant Eli Lilly & Co.: Consultant
    Patents/Royalties
    Royalties from Oxford Press for book

Anna Pink

  • Nothing to Disclose

Rosebud Roberts

  • Nothing to Disclose

Hanna Ruider

  • Nothing to Disclose

Gorazd B. Stokin

  • Nothing to Disclose